当前位置: 首页 > 期刊 > 《上海医药》 > 2017年第23期 > 正文
编号:13221970
雷腾舒治疗甲氨蝶呤反应不足类风湿关节炎患者群体药动学研究(4)
http://www.100md.com 2017年8月15日 上海医药2017年第23期
     [9] Lipsky PE, Tal XL. A potential new treatment for rheumatoid arthritis: thunder god vine[J]. Semin Arthritis Rheum, 1997, 26(5): 713-723.

    [10] Tao X, Younger J, Fan FZ, et al. Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study[J]. Arthritis Rheum, 2002, 46(7): 1735-1743.

    [11] Goldbach-Mansky R, Wilson M, Fleischmann R, et al. Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial[J]. Ann Intern Med, 2009, 151(4): 229-240, W49-W51.

    [12] Cibere J, Deng Z, Lin Y, et al. A randomized double blind, placebo controlled trial of topical Tripterygium wilfordii in rheumatoid arthritis: reanalysis using logistic regression analysis[J]. J Rheumato, 2003, 30(3): 465-467.

    [13] Macfarlane GJ, El-Metwally A, De Silva V, et al. Evidence for the efficacy of complementary and alternative medicines in the management of rheumatoid arthritis: a systematic review[J]. Rheumatology (Oxford), 2011, 50(9): 1672-1683. (夏文宏 张咏梅 苗红)
上一页1 2 3 4